Cargando…

The Use of Circulating Tumor DNA to Monitor and Predict Response to Treatment in Colorectal Cancer

Background: Colorectal cancer is one of the most common cancers worldwide and has a high mortality rate following disease recurrence. Treatment efficacy is maximized by providing tailored cancer treatment, ideally involving surgical resection and personalized neoadjuvant and adjuvant therapies, incl...

Descripción completa

Detalles Bibliográficos
Autores principales:	Reece, Mifanwy, Saluja, Hariti, Hollington, Paul, Karapetis, Christos S., Vatandoust, Sina, Young, Graeme P., Symonds, Erin L.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2019
Materias:	Genetics
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6881479/ https://www.ncbi.nlm.nih.gov/pubmed/31824558 http://dx.doi.org/10.3389/fgene.2019.01118

Ejemplares similares

The Use of Circulating Tumor DNA for Prognosis of Gastrointestinal Cancers
por: Saluja, Hariti, et al.
Publicado: (2018)

Circulating epigenetic biomarkers for detection of recurrent colorectal cancer
por: Symonds, Erin L., et al.
Publicado: (2020)

Serial Monitoring of Circulating Tumor DNA in Patients With Metastatic Colorectal Cancer to Predict the Therapeutic Response
por: Jia, Ning, et al.
Publicado: (2019)

A cross‐sectional study comparing a blood test for methylated BCAT1 and IKZF1 tumor‐derived DNA with CEA for detection of recurrent colorectal cancer
por: Young, Graeme P., et al.
Publicado: (2016)

Circulating Tumor DNA Response and Minimal Residual Disease Assessment in DNA Polymerase Epsilon-Mutated Colorectal Cancer Undergoing Immunotherapy
por: Lutfi, Areeb, et al.
Publicado: (2023)

Real‐world experience of nivolumab in the treatment of poor performance status patients with advanced non‐small cell lung cancer
por: Abbas, M. Nazim, et al.
Publicado: (2021)

Circulating tumour DNA for monitoring colorectal cancer—a prospective cohort study to assess relationship to tissue methylation, cancer characteristics and surgical resection
por: Symonds, Erin L., et al.
Publicado: (2018)

Fragment Enrichment of Circulating Tumor DNA With Low-Frequency Mutations
por: Liu, Xiaojun, et al.
Publicado: (2020)

Phase I open-label trial of intraperitoneal paclitaxel in combination with intravenous cisplatin and oral capecitabine in patients with advanced gastric cancer and peritoneal metastases (IPGP study): study protocol
por: Vatandoust, Sina, et al.
Publicado: (2019)

A longitudinal cohort study of watch and wait in complete clinical responders after chemo-radiotherapy for localised rectal cancer: study protocol
por: Vatandoust, Sina, et al.
Publicado: (2022)

Potential predictive value of circulating tumor DNA (ctDNA) mutations for the efficacy of immune checkpoint inhibitors in advanced triple-negative breast cancer
por: Tan, Qiaorui, et al.
Publicado: (2023)

Minimal residual disease (MRD) detection in solid tumors using circulating tumor DNA: a systematic review
por: Zhu, Lemei, et al.
Publicado: (2023)

Detection of circulating microRNAs with Ago2 complexes to monitor the tumor dynamics of colorectal cancer patients during chemotherapy
por: Fuji, Tomokazu, et al.
Publicado: (2019)

Copy Number Variation of Circulating Tumor DNA (ctDNA) Detected Using NIPT in Neoadjuvant Chemotherapy-Treated Ovarian Cancer Patients
por: Sharbatoghli, Mina, et al.
Publicado: (2022)

Sensitive Quantification of Cell-Free Tumor DNA for Early Detection of Recurrence in Colorectal Cancer
por: Stasik, Sebastian, et al.
Publicado: (2022)

An Excellent Response of Microsatellite Instability-High Pancreatic Adenocarcinoma to Pembrolizumab Treatment: The Role of Circulating Tumor DNA Testing
por: Anisetti, Bhrugun, et al.
Publicado: (2023)

Monitoring colorectal cancer following surgery using plasma circulating tumor DNA
por: Sun, Xiao, et al.
Publicado: (2018)

Circulating tumor DNA applications in monitoring the treatment of metastatic colorectal cancer patients
por: Kazemifard, Nesa, et al.
Publicado: (2019)

Regorafenib and Nivolumab or Pembrolizumab Combination and Circulating Tumor DNA Response Assessment in Refractory Microsatellite Stable Colorectal Cancer
por: Wang, Chongkai, et al.
Publicado: (2020)

Application of circulating tumour DNA in terms of prognosis prediction in Chinese follicular lymphoma patients
por: Zhao, Mengjing, et al.
Publicado: (2023)

Leveraging Fecal Bacterial Survey Data to Predict Colorectal Tumors
por: Zhang, Bangzhou, et al.
Publicado: (2019)

Erratum: Application of circulating tumour DNA in terms of prognosis prediction in chinese follicular lymphoma patients
por: Frontiers Production Office
Publicado: (2023)

DNA Repair–Related Gene Signature in Predicting Prognosis of Colorectal Cancer Patients
por: Lv, Min-Yi, et al.
Publicado: (2022)

Personalized treatment for advanced colorectal cancer: KRAS and beyond
por: Patel, Gargi Surendra, et al.
Publicado: (2013)

Impact of Plasmodium falciparum infection on DNA methylation of circulating immune cells
por: Almojil, Dareen, et al.
Publicado: (2023)

Evaluation of Methylation Biomarkers for Detection of Circulating Tumor DNA and Application to Colorectal Cancer
por: Mitchell, Susan M., et al.
Publicado: (2016)

Circulating tumour cell combined with DNA methylation for early detection of hepatocellular carcinoma
por: Liang, Wenjin, et al.
Publicado: (2022)

Circulating tumor cells and circulating tumor DNA in breast cancer diagnosis and monitoring
por: ALEMZADEH, EFFAT, et al.
Publicado: (2023)

Application of Circulating Tumor DNA as a Non-Invasive Tool for Monitoring the Progression of Colorectal Cancer
por: Zhou, Jiaolin, et al.
Publicado: (2016)

Treatment monitoring of colorectal cancer by integrated analysis of plasma concentration and sequencing of circulating tumor DNA
por: Yeh, Yu-Min, et al.
Publicado: (2020)

Circulating tumor DNA methylation marker MYO1-G for diagnosis and monitoring of colorectal cancer
por: Lin, Wu-Hao, et al.
Publicado: (2021)

Laparoscopic colopexy for neo-left colonic volvulus 10 years after anterior resection
por: Huynh, Roy, et al.
Publicado: (2020)

Assessment of tumor burden and response to therapy in patients with colorectal cancer using a quantitative ctDNA test for methylated BCAT1/IKZF1
por: Symonds, Erin L., et al.
Publicado: (2022)

Microbiota composition and its impact on DNA methylation in colorectal cancer
por: Gutierrez-Angulo, Melva, et al.
Publicado: (2023)

Detection of Cell Types Contributing to Cancer From Circulating, Cell-Free Methylated DNA
por: Barefoot, Megan E., et al.
Publicado: (2021)

Comparison of the structures and topologies of plasma extracted circulating nuclear and mitochondrial cell-free DNA
por: Pisareva, Ekaterina, et al.
Publicado: (2023)

Circulating tumor DNA in early response assessment and monitoring of advanced colorectal cancer treated with a multi-kinase inhibitor
por: Vandeputte, Caroline, et al.
Publicado: (2018)

The Circular RNA Profiles of Colorectal Tumor Metastatic Cells
por: Jiang, Weiqin, et al.
Publicado: (2018)

Dynamic monitoring of circulating tumor DNA to predict prognosis and efficacy of adjuvant chemotherapy after resection of colorectal liver metastases
por: Wang, De-Shen, et al.
Publicado: (2021)

A Prognostic Model Based on Nine DNA Methylation-Driven Genes Predicts Overall Survival for Colorectal Cancer
por: Feng, Zhongsheng, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_lqi090sr6n6afe16av8hvo4p5s